[HTML][HTML] Case report: adrenal pathology findings in severe COVID-19: an autopsy study

…, LA Hajjar, J Ordi, MVG Lacerda… - The American journal …, 2020 - ncbi.nlm.nih.gov
Although high mortality has been reported in many COVID-19 studies, very limited postmortem
information from complete autopsies is available. We report the findings in the adrenal …

[HTML][HTML] COVID-19 e estado de hipercoagulabilidade: uma nova perspectiva terapêutica

…, SI Rizk, IBSS Costa, MVG Lacerda… - Arquivos Brasileiros …, 2020 - SciELO Brasil
O novo coronavírus, designado como vírus da síndrome respiratória aguda grave (SARS-CoV-2,
sigla em inglês), é o responsável pelo surto da pneumonia viral que foi identificada …

[HTML][HTML] Respiratory complications of Plasmodium vivax malaria: systematic review and meta-analysis

…, Q Bassat, WM Monteiro, MVG Lacerda - The American journal …, 2017 - ncbi.nlm.nih.gov
Malaria, a major global public health problem, is mainly caused by Plasmodium falciparum
and Plasmodium vivax, and is responsible for nearly half a million deaths annually. Although …

Effect of high vs low doses of chloroquine diphosphate as adjunctive therapy for patients hospitalized with severe acute respiratory syndrome coronavirus 2 (SARS …

…, WM Monteiro, MVG Lacerda - JAMA network …, 2020 - jamanetwork.com
Importance There is no specific antiviral therapy recommended for coronavirus disease 2019
(COVID-19). In vitro studies indicate that the antiviral effect of chloroquine diphosphate (CQ…

Chloroquine diphosphate in two different dosages as adjunctive therapy of hospitalized patients with severe respiratory syndrome in the context of coronavirus (SARS …

…, WM Monteiro, MV Guimarães Lacerda… - MedRxiv, 2020 - medrxiv.org
Background There is no specific antiviral therapy recommended for the disease caused by
SARS-CoV-2 (COVID-19). Recent publications have drawn attention to the possible benefit of …

Methylprednisolone as adjunctive therapy for patients hospitalized with coronavirus disease 2019 (COVID-19; Metcovid): a randomized, double-blind, phase IIb …

…, MS Xavier, WM Monteiro, MVG Lacerda - Clinical Infectious …, 2021 - academic.oup.com
Background Steroid use for coronavirus disease 2019 (COVID-19) is based on the possible
role of these drugs in mitigating the inflammatory response, mainly in the lungs, triggered by …

[HTML][HTML] COVID-19 in Brazil: advantages of a socialized unified health system and preparation to contain cases

…, WM Monteiro, MVG Lacerda - Revista da Sociedade …, 2020 - SciELO Brasil
The outbreak of new coronavirus disease 2019 (COVID-19) reported for the first time in Wuhan,
China in late December 2019 have rapidly spread to other countries and it was declared …

Methylprednisolone as adjunctive therapy for patients hospitalized with COVID-19 (Metcovid): a randomised, double-blind, phase IIb, placebo-controlled trial

…, MS Xavier, WM Monteiro, MVG Lacerda - 2020 - arca.fiocruz.br
Background: Steroid use for COVID-19 is based on the possible role of these drugs in
mitigating the inflammatory response, mainly in the lungs, triggered by SARS-CoV-2. This study …

[HTML][HTML] Thrombocytopenia in malaria: who cares?

MVG Lacerda, MPG Mourão, HCC Coelho… - Memorias do Instituto …, 2011 - SciELO Brasil
Despite not being a criterion for severe malaria, thrombocytopenia is one of the most
common complications of both Plasmodium vivax and Plasmodium falciparum malaria. In a …

Guillain–Barré syndrome associated with SARS-CoV-2 infection in a pediatric patient

…, M de Souza Bastos, MVG Lacerda - Journal of tropical …, 2021 - academic.oup.com
We report the case of a 15-year-old male patient presenting frontal headaches with retro-orbital
pain accompanied by fever evolving to weakness and pain of the lower limbs, which …